Although recent data regarding the effect of CpdA on the expression of Th cytokines in various animal models of immune diseases has been presented [7], [8], the molecular mechanism underlying differential effects of a selective modulation of GR in immune cells on downstream TF targets has not yet been clarified. The gene discussed is NR3C1; the disease is immune system disorder.